Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
Main Authors: | Weirui Li, Leilei Guo, Zikang Xing, Xin Fang, Heng Liang, Shengnan Zhang, Lei Shi, Chunxiang Kuang, Leming Shi, Yuanting Zheng, Yueqing Hu, Qing Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.330 |
Similar Items
-
Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
by: Yoshiki Kudo, et al.
Published: (2020-12-01) -
Indoleamine 2,3-dioxygenase in endometriosis
by: Hui-Li Yang, et al.
Published: (2019-01-01) -
Reactivities of indoleamine 2,3-dioxygenases
by: Kuo, Hsin Hen
Published: (2013) -
Reactivities of indoleamine 2,3-dioxygenases
by: Kuo, Hsin Hen
Published: (2013) -
Human indoleamine 2,3-dioxygenase
by: Papadopoulou, Nektaria D.
Published: (2006)